CLN5 in Heterozygosis May Protect Against the Development of Tumors in a VHL Patient
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Orphanet Journal of Rare Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CLN5 in Heterozygosis May Protect Against the Development of Tumors in a VHL Patient
Orphanet J Rare Dis 2020 Jun 02;[EPub Ahead of Print], I de Rojas-P, V Albiñana, L Recio-Poveda, A Rodriguez-Rufián, ÁM Cuesta, LM BotellaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.